Rare Biomarkers Specimen Collection And Stabilization Market Size, Share, & Trends Report

Rare Biomarkers Specimen Collection And Stabilization Market Size, Share, & Trends Analysis Report By Biomarker & Product (Tubes, Isolation Kits), By End Use, By Region, And Segment Forecasts, 2020 - 2027

  • Report ID: GVR-4-68038-459-8
  • Number of Pages: 209
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2018
  • Industry: Healthcare

Table of Contents

Chapter 1 Executive Summary
                    1.1 Market Summary
Chapter 2 Research Methodology
                    2.1 Information Procurement
                    2.2 Information or Data Analysis
                    2.3 Market Scope & Segment Definition
                         2.3.1 Biomarker & Products
                              2.3.1.1 Circulating Cell-Free DNA (ccfDNA)
                              2.3.1.2 Circulating Tumor Cells (CTCs)
                              2.3.1.3 Exosomes/Extracellular Vesicles
                              2.3.1.4 Circulating Cell Free RNA (ccfRNA)/miRNA
                         2.3.2 End Use
                              2.3.2.1 Research
                              2.3.2.2 Diagnostics
                    2.4 Market Model
                         2.4.1 Ancillary market study
                              2.4.1.1 CTC market, by technology
                              2.4.1.2 CTC market, by product
                              2.4.1.3 CTCs market, by application
                         2.4.2 Rare biomarkers specimen collection & stabilization market study
                              2.4.2.1 Market study, by biomarkers
                              2.4.2.2 Exosomes & ccfRNA/miRNA, by product, specimen, nucleic acid, & application
                         2.4.3 Market study, by end use
                         2.4.4 Regional analysis
Chapter 3 Market Variables, Trends & Scope
                    3.1 Market segmentation
                    3.2 Rare Biomarkers Specimen Collection & Stabilization Market: Industry Pyramid Analysis
                    3.3 Penetration and Growth Prospect Mapping for Biomarker, 2019
                    3.4 Market Dynamics
                         3.4.1 Market driver analysis
                              3.4.1.1 Technological advancements in biomarker isolation
                         3.4.2 Expanding applications of rare biomarkers specimen
                         3.4.3 Growing awareness About early and rapid cancer diagnosis
                         3.4.4 Rise in investments in liquid biopsy and prenatal tests
                    3.5 Market Restraint Analysis
                         3.5.1 Technical challenges in biomarker isolation
                         3.5.2 Challenges associated with clinical implementation
                    3.6 Market Opportunity Analysis
                         3.6.1 Growth in government and non-government initiatives for exosome research
                    3.7 Pricing Analysis
                         3.7.1 Conclusion
                    3.8 Technology Mapping
                    3.9 SWOT analysis, by factor (Political & legal, economic, and technological)
                    3.10 Porter’s Five Forces Analysis
                    3.11 Major deals and strategic alliances analysis
                         3.11.1 New product launch
                         3.11.2 Mergers and acquisitions
                         3.11.3 Partnerships
Chapter 4 Biomarker & Product Business Analysis
                    4.1 Market: Biomarker & Product Movement Analysis
                    4.2 Circulating Cell Free DNA (ccfDNA)
                         4.2.1 Market, 2015 - 2027 (USD Million)
                    4.3 Circulating Tumor Cells (CTC)
                         4.3.1 Market, 2015 - 2027 (USD Million)
                    4.4 Exosomes/Extracellular Vesicles
                         4.4.1 Market, 2015 - 2027 (USD Million)
                         4.4.2 Exosomes/extracellular vesicles collection & stabilization market, by product
                              4.4.2.1 Isolation kits & reagents
                                   4.4.2.1.1 Market for exosomes/extracellular vesicles collection & stabilization, 2015 - 2027 (USD Million)
                              4.4.2.2 Blood collection tubes
                                  4.4.2.2.1 Market for exosomes/extracellular vesicles collection & stabilization, 2015 - 2027 (USD Million)
                              4.4.2.3 Systems
                                  4.4.2.3.1 Market for exosomes/extracellular vesicles collection & stabilization, 2015 - 2027 (USD Million)
                         4.4.3 Market, By specimen
                              4.4.3.1 Serum/Plasma
                                  4.4.3.1.1 Market, 2015 - 2027 (USD Million)
                              4.4.3.2 Other specimens
                                  4.4.3.2.1 Market, 2015 - 2027 (USD Million)
                         4.4.4 Exosomes/extracellular vesicles collection & stabilization market, By nucleic acid
                              4.4.4.1 RNA
                                  4.4.4.1.1 Market, 2015 - 2027 (USD Million)
                              4.4.4.2 DNA
                                  4.4.4.2.1 Market, 2015 - 2027 (USD Million)
                              4.4.4.3 Other component
                                  4.4.4.3.1 Market, 2015 - 2027 (USD Million)
                         4.4.5 Exosomes/extracellular vesicles collection & stabilization market, by application
                              4.4.5.1 NIPT (research)
                                  4.4.5.1.1 Market for NIPT (research), 2015 - 2027 (USD Million)
                              4.4.5.2 Oncology (research and diagnostics)
                                  4.4.5.2.1 Market for oncology (research and diagnostics), 2015 - 2027 (USD Million)
                                  4.4.5.2.2 Oncology (research)
                                       4.4.5.2.2.1 Market for oncology (research), 2015 - 2027 (USD Million)
                                  4.4.5.2.3 Oncology (diagnostics)
                                       4.4.5.2.3.1 Market for oncology (diagnostics), 2015 - 2027 (USD Million)
                                       4.4.5.2.3.2 Oncology screening
                                       4.4.5.2.3.3 Market for oncology screening, 2015 - 2027 (USD Million)
                                       4.4.5.2.3.4 Treatment monitoring
                                       4.4.5.2.3.5 Market for treatment monitoring, 2015 - 2027 (USD Million)
                              4.4.5.3 Transcriptomics (research)
                                  4.4.5.3.1 Market for transcriptomics (research), 2015 - 2027 (USD Million)
                              4.4.5.4 Pharmacogenomics (research)
                                  4.4.5.4.1 Market for pharmacogenomics (research), 2015 - 2027 (USD Million)
                              4.4.5.5 Transplant rejection (research)
                                  4.4.5.5.1 Market for transplant rejection (research), 2015 - 2027 (USD Million)
                              4.4.5.6 Population screening (research)
                                  4.4.5.6.1 Market for Population screening (research), 2015 - 2027 (USD Million)
                              4.4.5.7 Cardiovascular diseases (research)
                                  4.4.5.7.1 Market for Cardiovascular diseases (research), 2015 - 2027 (USD Million)
                              4.4.5.8 Other applications
                                  4.4.5.8.1 Market for other applications (research), 2015 - 2027 (USD Million)
                    4.5 Circulating Cell Free RNA (ccfRNA) / miRNA
                         4.5.1 Market, 2015 - 2027 (USD Million)
                         4.5.2 Market, By Product
                              4.5.2.1 Isolation kits & reagents
                                  4.5.2.1.1 Market for Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization, 2015 - 2027 (USD Million)
                              4.5.2.2 Blood collection tubes
                                  4.5.2.2.1 Market for Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization, 2015 - 2027 (USD Million)
                         4.5.3 Market, by application
                              4.5.3.1 NIPT (research)
                                  4.5.3.1.1 Market for NIPT (research), 2015 - 2027 (USD Million)
                              4.5.3.2 Oncology (research)
                                  4.5.3.2.1 Market for oncology (research), 2015 - 2027 (USD Million)
                              4.5.3.3 Transcriptomics (research)
                                  4.5.3.3.1 Market for transcriptomics (research), 2015 - 2027 (USD Million)
                              4.5.3.4 Pharmacogenomics (research)
                                  4.5.3.4.1 Market for Pharmacogenomics (research), 2015 - 2027 (USD Million)
                              4.5.3.5 Transplant rejection (research)
                                  4.5.3.5.1 Market for Transplant rejection (research), 2015 - 2027 (USD Million)
                              4.5.3.6 Population screening (research)
                                  4.5.3.6.1 Market for Population screening (research), 2015 - 2027 (USD Million)
                              4.5.3.7 Cardiovascular diseases (research)
                                  4.5.3.7.1 Market for Cardiovascular diseases (research), 2015 - 2027 (USD Million)
                              4.5.3.8 Other applications
                                  4.5.3.8.1 Market for other applications (research), 2015 - 2027 (USD Million)
Chapter 5 End-Use Business Analysis
                    5.1 Market: End-use Movement Analysis
                    5.2 Research
                         5.2.1 Market for research, 2015 - 2027 (USD Million)
                         5.2.2 Research Labs/CROs
                              5.2.2.1 Market for research Labs/CROs, 2015 - 2027 (USD Million)
                         5.2.3 Academic Institutes
                              5.2.3.1 Market for Academic Institutes, 2015 - 2027 (USD Million)
                    5.3 Diagnostics
                         5.3.1 Market for diagnostics, 2015 - 2027 (USD Million)
                         5.3.2 Laboratories
                              5.3.2.1 Market for laboratories, 2015 - 2027 (USD Million)
                         5.3.3 Hospitals
                              5.3.3.1 Market for hospitals, 2015 - 2027 (USD Million)
                         5.3.4 Prenatal clinic
                              5.3.4.1 Market for prenatal clinics, 2015 - 2027 (USD Million)
Chapter 6 Regional Business Analysis
                    6.1 Market: Regional Movement Analysis
                    6.2 North America
                         6.2.1 Market estimates and forecast, 2015 - 2027 (USD Million)
                         6.2.2 U.S.
                              6.2.2.1 Market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.2.2.2 Market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.2.3 Canada
                              6.2.3.1 Market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.2.3.2 Market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                    6.3 Europe
                         6.3.1 Europe rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
                         6.3.2 Germany
                              6.3.2.1 Germany rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.3.2.2 Germany rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.3.3 U.K.
                              6.3.3.1 U.K. rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.3.3.2 U.K. rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.3.4 Spain
                              6.3.4.1 Spain rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.3.4.2 Spain rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.3.5 France
                              6.3.5.1 France rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.3.5.2 France rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.3.6 Italy
                              6.3.6.1 Italy rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.3.6.2 Italy rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.3.7 Netherlands
                              6.3.7.1 Netherlands rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.3.7.2 Netherlands rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                    6.4 Asia Pacific
                         6.4.1 Asia Pacific rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
                         6.4.2 Japan
                              6.4.2.1 Japan rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.4.2.2 Japan rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.4.3 China
                              6.4.3.1 China rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.4.3.2 China rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.4.4 India
                              6.4.4.1 India rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.4.4.2 India rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.4.5 South Korea
                              6.4.5.1 South Korea rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.4.5.2 South Korea rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.4.6 Singapore
                              6.4.6.1 Singapore rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.4.6.2 Singapore rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.4.7 Australia
                              6.4.7.1 Australia rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.4.7.2 Australia rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                         6.4.8 South East Asia
                              6.4.8.1 South East Asia rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.4.8.2 South East Asia rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                    6.5 Latin America
                         6.5.1 Latin America rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
                         6.5.2 Brazil
                              6.5.2.1 Brazil rare biomarkers specimen collection & stabilization market estimates and forecast, by biomarkers & product, 2015 - 2027 (USD Million)
                              6.5.2.2 Brazil rare biomarkers specimen collection & stabilization market estimates and forecast, by end use, 2015 - 2027 (USD Million)
                    6.6 Middle East and Africa
                         6.6.1 Middle-East and Africa rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
                         6.6.2 South Africa
                              6.6.2.1 Market estimates and forecast, by biomarker & product, 2015 - 2027 (USD Million)
                              6.6.2.2 Market estimates and forecast, by end use, 2015 - 2027 (USD Million)
Chapter 7 Company Profile
                    7.1 Company Profiles
                         7.1.1 Agena Bioscience
                              7.1.1.1 Company overview
                              7.1.1.2 Product benchmarking
                              7.1.1.3 Strategic initiatives
                         7.1.2 ANGLE plc
                              7.1.2.1 Company overview
                              7.1.2.2 Financial Performance
                              7.1.2.3 Product benchmarking
                              7.1.2.4 Strategic initiatives
                         7.1.3 AS ONE INTERNATIONAL
                              7.1.3.1 Company overview
                              7.1.3.2 Product benchmarking
                         7.1.4 BioChain Institute, Inc.
                              7.1.4.1 Company overview
                              7.1.4.2 Product benchmarking
                         7.1.5 Biolidics Limited
                              7.1.5.1 Company overview
                              7.1.5.2 Financial Performance
                              7.1.5.3 Product benchmarking
                              7.1.5.4 Strategic initiatives
                         7.1.6 Biomatrica
                              7.1.6.1 Company overview
                              7.1.6.2 Financial Performance
                              7.1.6.3 Product benchmarking
                              7.1.6.4 Strategic initiatives
                         7.1.7 Bio-Techne Corporation
                              7.1.7.1 Company overview
                              7.1.7.2 Advanced Cell Diagnostics, Inc.
                                  7.1.7.2.1 Company overview
                              7.1.7.3 Novus Biologicals, LLC
                                  7.1.7.3.1 Company overview
                              7.1.7.4 Financial Performance
                              7.1.7.5 Product benchmarking
                              7.1.7.6 Strategic initiatives
                         7.1.8 BioVision, Inc.
                              7.1.8.1 Company overview
                              7.1.8.2 Product benchmarking
                              7.1.8.3 Strategic initiatives
                         7.1.9 Caltag Medsystems Limited
                              7.1.9.1 Company overview
                              7.1.9.2 Cytomark Ltd.
                              7.1.9.2.1 Company overview
                              7.1.9.3 Product benchmarking
                         7.1.10 OraSure Technologies Inc.
                              7.1.10.1 Company overview
                              7.1.10.2 DNA Genotek, Inc.
                                  7.1.10.2.1 Company overview
                              7.1.10.3 Financial Performance
                              7.1.10.4 Product benchmarking
                              7.1.10.5 Strategic initiatives
                         7.1.11 Epic Sciences
                              7.1.11.1 Company overview
                              7.1.11.2 Product benchmarking
                              7.1.11.3 Strategic initiatives
                         7.1.12 EpiGentek Group Inc.
                              7.1.12.1 Company overview
                              7.1.12.2 Product benchmarking
                              7.1.12.3 Strategic initiatives
                         7.1.13 F. Hoffmann-La Roche Ltd
                              7.1.13.1 Company overview
                              7.1.13.2 Financial Performance
                              7.1.13.3 Product benchmarking
                              7.1.13.4 Strategic initiatives
                         7.1.14 Fluxion Biosciences, Inc.
                              7.1.14.1 Company overview
                              7.1.14.2 Product benchmarking
                              7.1.14.3 Strategic initiatives
                         7.1.15 Geno Technology Inc., USA.
                              7.1.15.1 Company overview
                              7.1.15.2 Product benchmarking
                         7.1.16 Genomax Technologies Pte Ltd.
                              7.1.16.1 Company overview
                              7.1.16.2 Product benchmarking
                              7.1.16.3 Strategic initiatives
                         7.1.17 GILUPI GmbH
                              7.1.17.1 Company overview
                              7.1.17.2 Product benchmarking
                              7.1.17.3 Strategic initiatives
                         7.1.18 Norgen Biotek Corp.
                              7.1.18.1 Company overview
                              7.1.18.2 Product benchmarking
                              7.1.18.3 Strategic initiatives
                         7.1.19 Promega Corporation
                              7.1.19.1 Company overview
                              7.1.19.2 Financial Performance
                              7.1.19.3 Product benchmarking
                              7.1.19.4 Strategic initiatives
                         7.1.20 Rarecells Diagnostics SAS
                              7.1.20.1 Company overview
                              7.1.20.2 Financial Performance
                              7.1.20.3 Product benchmarking
                         7.1.21 SiO2 Materials Science
                              7.1.21.1 Company overview
                              7.1.21.2 Product benchmarking
                         7.1.22 QIAGEN
                              7.1.22.1 Company overview
                              7.1.22.2 PreAnalytiX GmbH
                                  7.1.22.2.1 Company overview
                              7.1.22.3 Financial Performance
                              7.1.22.4 Product benchmarking
                              7.1.22.5 Strategic initiatives
                         7.1.23 RareCyte, Inc.
                              7.1.23.1 Company overview
                              7.1.23.2 Product benchmarking
                              7.1.23.3 Strategic initiatives
                         7.1.24 siemens Healthineers
                              7.1.24.1 Company overview
                              7.1.24.2 Financial Performance
                              7.1.24.3 Product benchmarking
                              7.1.24.4 Strategic initiatives
                         7.1.25 STEMCELL Technologies Inc.
                              7.1.25.1 Company overview
                              7.1.25.2 Financial Performance
                              7.1.25.3 Product benchmarking
                              7.1.25.4 Strategic initiatives
                         7.1.26 Streck, Inc.
                              7.1.26.1 Company overview
                              7.1.26.2 Product benchmarking
                         7.1.27 Thermo Fisher Scientific, Inc.
                              7.1.27.1 Company overview
                              7.1.27.2 Financial Performance
                              7.1.27.3 Product benchmarking
                              7.1.27.4 Strategic initiatives
                         7.1.28 Vortex Biosciences
                              7.1.28.1 Company overview
                              7.1.28.2 Product benchmarking
                              7.1.28.3 Strategic initiatives
                         7.1.29 VyCAP B.V.
                              7.1.29.1 Company overview
                              7.1.29.2 Product benchmarking
                         7.1.30 LifeSpan BioSciences, Inc
                              7.1.30.1 Company overview
                              7.1.30.2 Product benchmarking
                              7.1.30.3 Strategic initiatives
                         7.1.31 MagBio Genomics Inc.
                              7.1.31.1 Company overview
                              7.1.31.2 Product benchmarking
                              7.1.31.3 Strategic initiatives
                         7.1.32 Menarini Silicon Biosystems
                              7.1.32.1 Company overview
                              7.1.32.2 Product benchmarking
                              7.1.32.3 Strategic initiatives
                         7.1.33 MyBioSource.com
                              7.1.33.1 Company overview
                              7.1.33.2 Product benchmarking
                         7.1.34 Precision for Medicine, Inc.
                              7.1.34.1 Company overview
                              7.1.34.2 ApoCell, Inc.
                                  7.1.34.2.1 Company overview
                              7.1.34.3 Product benchmarking
                              7.1.34.4 Strategic initiatives


List Of Tables

Table 1 Products for CTC analysis by application
Table 2 Exosome isolation products, by specimen type
Table 3 Product classification with regard to usage type
Table 4 Distribution network for EpiGentek Group, Inc.’s EpiQuik Circulating Cell-Free DNA isolation kit
Table 5 Examples of CTC isolation technologies other than CellSearch system
Table 6 Liquid biopsy developing or commercializing companies
Table 7 Funding initiatives by NIH for exosome projects
Table 8 Blood collection tubes: Pricing analysis, by company
Table 9 Kits & reagents: Pricing analysis, by company
Table 10 Comparison of conventional and microfluidics-based exosome isolation techniques
Table 11 Products for CTC detection & enrichment
Table 12 Methodological variables in processing and analysis of ccfDNA
Table 13 Comparative analysis of qEV and SmartSEC
Table 14 Clinically relevant exosomal nucleic acid markers for breast cancer, as per the research studies
Table 15 Comparison of circulating miRNA, DNA, and Biopsy
Table 16 Selected circulating cfRNA biomarkers in cancer
Table 17 North America rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 18 North America exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 19 North America exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 20 North America exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 21 North America exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 22 North America exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 23 North America exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 24 North America Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 25 North America Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 26 North America Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 27 North America rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 28 North America exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 29 North America exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 30 U.S. rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 31 U.S. exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 32 U.S. exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 33 U.S. exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 34 U.S. exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 35 U.S. exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 36 U.S. exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 37 U.S. Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 38 U.S. Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 39 U.S. Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 40 U.S. rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 41 U.S. exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 42 U.S. exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 43 Canada rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 44 Canada exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 45 Canada exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 46 Canada exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 47 Canada exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 48 Canada exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 49 Canada exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 50 Canada Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 51 Canada Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 52 Canada Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 53 Canada rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 54 Canada exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 55 Canada exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 56 Europe rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 57 Europe exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 58 Europe exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 59 Europe exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 60 Europe exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 61 Europe exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 62 Europe exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 63 Europe Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 64 Europe Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 65 Europe Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 66 Europe rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 67 Europe exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 68 Europe exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 69 Germany rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 70 Germany exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 71 Germany exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 72 Germany exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 73 Germany exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 74 Germany exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 75 Germany exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 76 Germany Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 77 Germany Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 78 Germany Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 79 Germany rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 80 Germany exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 81 Germany exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 82 U.K. rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 83 U.K. exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 84 U.K. exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 85 U.K. exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 86 U.K. exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 87 U.K. exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 88 U.K. exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 89 U.K. Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 90 U.K. Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 91 U.K. Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 92 U.K. rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 93 U.K. exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 94 U.K. exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 95 Spain rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 96 Spain exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 97 Spain exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 98 Spain exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 99 Spain exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 100 Spain exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 101 Spain exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 102 Spain Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 103 Spain Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 104 Spain Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 105 Spain rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 106 Spain exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 107 Spain exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 108 France rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 109 France exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 110 France exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 111 France exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 112 France exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 113 France exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 114 France exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 115 France Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 116 France Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 117 France Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 118 France rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 119 France exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 120 France exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 121 Italy rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 122 Italy exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 123 Italy exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 124 Italy exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 125 Italy exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 126 Italy exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 127 Italy exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 128 Italy Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 129 Italy Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 130 Italy Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 131 Italy rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 132 Italy exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 133 Italy exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 134 Netherlands rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 135 Netherlands exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 136 Netherlands exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 137 Netherlands exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 138 Netherlands exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 139 Netherlands exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 140 Netherlands exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 141 Netherlands Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 142 Netherlands Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 143 Netherlands Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 144 Netherlands rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 145 Netherlands exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 146 Netherlands exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 147 Asia Pacific rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 148 Asia Pacific exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 149 Asia Pacific exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 150 Asia Pacific exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 151 Asia Pacific exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 152 Asia Pacific exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 153 Asia Pacific exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 154 Asia Pacific Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 155 Asia Pacific Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 156 Asia Pacific Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 157 Asia Pacific rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 158 Asia Pacific exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 159 Asia Pacific exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 160 Japan rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 161 Japan exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 162 Japan exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 163 Japan exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 164 Japan exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 165 Japan exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 166 Japan exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 167 Japan Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 168 Japan Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 169 Japan Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 170 Japan rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 171 Japan exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 172 Japan exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 173 China rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 174 China exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 175 China exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 176 China exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 177 China exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 178 China exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 179 China exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 180 China Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 181 China Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 182 China Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 183 China rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 184 China exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 185 China exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 186 India rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 187 India exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 188 India exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 189 India exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 190 India exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 191 India exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 192 India exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 193 India Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 194 India Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 195 India Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 196 India rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 197 India exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 198 India exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 199 South Korea rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 200 South Korea exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 201 South Korea exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 202 South Korea exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 203 South Korea exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 204 South Korea exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 205 South Korea exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 206 South Korea Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 207 South Korea Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 208 South Korea Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 209 South Korea rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 210 South Korea exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 211 South Korea exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 212 Singapore rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 213 Singapore exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 214 Singapore exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 215 Singapore exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 216 Singapore exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 217 Singapore exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 218 Singapore exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 219 Singapore Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 220 Singapore Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 221 Singapore Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 222 Singapore rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 223 Singapore exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 224 Singapore exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 225 Australia rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 226 Australia exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 227 Australia exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 228 Australia exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 229 Australia exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 230 Australia exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 231 Australia exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 232 Australia Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 233 Australia Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 234 Australia Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 235 Australia rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 236 Australia exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 237 Australia exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 238 South East Asia rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 239 South East Asia exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 240 South East Asia exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 241 South East Asia exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 242 South East Asia exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 243 South East Asia exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 244 South East Asia exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 245 South East Asia Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 246 South East Asia Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 247 South East Asia Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 248 South East Asia rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 249 South East Asia exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 250 South East Asia exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 251 Latin America rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 252 Latin America exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 253 Latin America exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 254 Latin America exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 255 Latin America exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 256 Latin America exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 257 Latin America exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 258 Latin America Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 259 Latin America Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 260 Latin America Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 261 Latin America rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 262 Latin America exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 263 Latin America exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 264 Brazil rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 265 Brazil exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 266 Brazil exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 267 Brazil exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 268 Brazil exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 269 Brazil exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 270 Brazil exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 271 Brazil Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 272 Brazil Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 273 Brazil Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 274 Brazil rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 275 Brazil exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 276 Brazil exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 277 MEA rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 278 MEA exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 279 MEA exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 280 MEA exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 281 MEA exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 282 MEA exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 283 MEA exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 284 MEA Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 285 MEA Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 286 MEA Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 287 MEA rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 288 MEA exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 289 MEA exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 290 South Africa rare biomarkers specimen collection & stabilization market estimates & forecasts, by biomarker, 2015 - 2027 (USD Million)
Table 291 South Africa exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 292 South Africa exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by specimen type, 2015 - 2027 (USD Million)
Table 293 South Africa exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by nucleic acid & other biomolecules, 2015 - 2027 (USD Million)
Table 294 South Africa exosomes/extracellular vesicles collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 295 South Africa exosomes/extracellular vesicles collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 296 South Africa exosomes/extracellular vesicles collection & stabilization market for oncology diagnostics estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 297 South Africa Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by product, 2015 - 2027 (USD Million)
Table 298 South Africa Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 299 South Africa Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology estimates & forecasts, by application, 2015 - 2027 (USD Million)
Table 300 South Africa rare biomarkers specimen collection & stabilization market estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 301 South Africa exosomes/extracellular vesicles collection & stabilization market for research settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)
Table 302 South Africa exosomes/extracellular vesicles collection & stabilization market for diagnostics settings estimates & forecasts, by end use, 2015 - 2027 (USD Million)


List of Figures

Fig. 1 Rare biomarkers specimen collection & stabilization market snapshot
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Industry pyramid analysis
Fig. 5 Industry pyramid analysis
Fig. 6 Market research approaches
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 Industry pyramid analysis
Fig. 9 Industry pyramid analysis
Fig. 10 Market model for CTCs market
Fig. 11 Penetration of molecules in liquid biopsy market
Fig. 12 Penetration of CTCs isolation & enrichment technologies
Fig. 13 Penetration of molecules in liquid biopsy market
Fig. 14 QFD modeling for market share assessment for exosome segment, by product type
Fig. 15 QFD modeling for market share assessment for exosome segment, by nucleic acid type
Fig. 16 Penetration of rare biomarkers specimen type, by end use settings
Fig. 17 Penetration of rare biomarkers specimen within end use setting, 2019
Fig. 18 Regional analysis for CTCs penetration in therapy selection
Fig. 19 Regional analysis for CTCs penetration in disease diagnosis
Fig. 20 Rare biomarkers specimen collection & stabilization market segmentation
Fig. 21 Industry pyramid analysis
Fig. 22 Penetration and growth prospect mapping for biomarker, 2019
Fig. 23 Rare biomarkers specimen collection & stabilization market driver impact
Fig. 24 In vitro diagnostic market restraint impact
Fig. 25 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 26 Porter’s Five Forces Analysis
Fig. 27 Rare biomarkers specimen collection stabilization market: Biomarker & product outlook and key takeaways
Fig. 28 Rare biomarkers specimen collection stabilization market: Biomarker & product movement analysis
Fig. 29 Critical in vivo & ex-vivo pre-analytical factors in ccfDNA analysis
Fig. 30 ccfDNA yield extracted serum & plasma in ng/ml
Fig. 31 Global circulating Cell Free DNA (ccfDNA) collection & stabilization market, 2015 - 2027 (USD Million)
Fig. 32 Global Circulating Tumor Cells (CTC) collection & stabilization market, 2015 - 2027 (USD Million)
Fig. 33 Global exosomes/extracellular vesicles collection & stabilization market, 2015 - 2027 (USD Million)
Fig. 34 Global isolation kits & reagents market for exosomes/extracellular vesicles collection & stabilization, 2015 - 2027 (USD Million)
Fig. 35 Global blood collection tubes market for exosomes/extracellular vesicles collection & stabilization, 2015 - 2027 (USD Million)
Fig. 36 Global systems market for exosomes/extracellular vesicles collection & stabilization, 2015 - 2027 (USD Million)
Fig. 37 Global serum/plasma-derived exosomes/extracellular vesicles collection & stabilization market, 2015 - 2027 (USD Million)
Fig. 38 Global other specimens-derived exosomes/extracellular vesicles collection & stabilization market, 2015 - 2027 (USD Million)
Fig. 39 Global exosomes/extracellular vesicles RNA collection & stabilization market, 2015 - 2027 (USD Million)
Fig. 40 Global exosomes/extracellular vesicles DNA collection & stabilization market, 2015 - 2027 (USD Million)
Fig. 41 Global exosomes/extracellular vesicles other component collection & stabilization market, 2015 - 2027 (USD Million)
Fig. 42 Global exosomes/extracellular vesicles collection & stabilization market for NIPT (research), 2015 - 2027 (USD Million)
Fig. 43 Global exosomes/extracellular vesicles collection & stabilization market for oncology (research and diagnostics), 2015 - 2027 (USD Million)
Fig. 44 Number of papers published in the last decade in cancer EVs research, as per SCOPUS database
Fig. 45 Global exosomes/extracellular vesicles collection & stabilization market for oncology (research), 2015 - 2027 (USD Million)
Fig. 46 Global exosomes/extracellular vesicles collection & stabilization market for oncology (diagnostics), 2015 - 2027 (USD Million)
Fig. 47 Global exosomes/extracellular vesicles collection & stabilization market for oncology screening, 2015 - 2027 (USD Million)
Fig. 48 Global exosomes/extracellular vesicles collection & stabilization market for treatment monitoring, 2015 - 2027 (USD Million)
Fig. 49 Global exosomes/extracellular vesicles collection & stabilization market for transcriptomic (research), 2015 - 2027 (USD Million)
Fig. 50 Global exosomes/extracellular vesicles collection & stabilization market for pharmacogenomics (research), 2015 - 2027 (USD Million)
Fig. 51 Global exosomes/extracellular vesicles collection & stabilization market for transplant rejection (research), 2015 - 2027 (USD Million)
Fig. 52 Global exosomes/extracellular vesicles collection & stabilization market for population screening (research), 2015 - 2027 (USD Million)
Fig. 53 Global exosomes/extracellular vesicles collection & stabilization market for cardiovascular diseases (research), 2015 - 2027 (USD Million)
Fig. 54 Global exosomes/extracellular vesicles collection & stabilization market for other applications (research), 2015 - 2027 (USD Million)
Fig. 55 Global Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market, 2015 - 2027 (USD Million)
Fig. 56 Global isolation kits & reagents market for Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization, 2015 - 2027 (USD Million)
Fig. 57 Global blood collection tubes market for Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization, 2015 - 2027 (USD Million)
Fig. 58 Global Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for NIPT (research), 2015 - 2027 (USD Million)
Fig. 59 Global Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for oncology (research), 2015 - 2027 (USD Million)
Fig. 60 Global Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for transcriptomics (research), 2015 - 2027 (USD Million)
Fig. 61 Global Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for pharmacogenomics (research), 2015 - 2027 (USD Million)
Fig. 62 Global Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for transplant rejection (research), 2015 - 2027 (USD Million)
Fig. 63 Global Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for population screening (research), 2015 - 2027 (USD Million)
Fig. 64 Global Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for cardiovascular diseases (research), 2015 - 2027 (USD Million)
Fig. 65 Global Circulating Cell Free RNA (ccfRNA) / miRNA collection & stabilization market for other applications (research), 2015 - 2027 (USD Million)
Fig. 66 Rare biomarkers specimen collection stabilization market: End-use outlook and key takeaways
Fig. 67 Rare biomarkers specimen collection stabilization market: End-use movement analysis
Fig. 68 Global rare biomarkers specimen collection stabilization market for research, 2015 - 2027 (USD Million)
Fig. 69 Global rare biomarkers specimen collection stabilization market for research labs/CROs, 2015 - 2027 (USD Million)
Fig. 70 Global rare biomarkers specimen collection stabilization market for academic institutes, 2015 - 2027 (USD Million)
Fig. 71 Global rare biomarkers specimen collection stabilization market for diagnostics, 2015 - 2027 (USD Million)
Fig. 72 Global rare biomarkers specimen collection stabilization market for laboratories, 2015 - 2027 (USD Million)
Fig. 73 Global rare biomarkers specimen collection stabilization market for hospitals, 2015 - 2027
Fig. 74 Global rare biomarkers specimen collection stabilization market for prenatal clinics, 2015 - 2027 (USD Million)
Fig. 75 Rare biomarkers specimen collection & stabilization market: Regional outlook and key takeaways
Fig. 76 Rare biomarkers specimen collection & stabilization market: Regional movement analysis
Fig. 77 North America
Fig. 78 North America rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 79 U.S.
Fig. 80 U.S. rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 81 Canada
Fig. 82 Canada rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 83 Europe
Fig. 84 Europe rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 85 Germany
Fig. 86 Germany rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 87 U.K.
Fig. 88 U.K. rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 89 Spain
Fig. 90 Spain rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 91 France
Fig. 92 France rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 93 Italy
Fig. 94 Italy rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 95 Netherlands
Fig. 96 Netherlands rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 97 Asia Pacific
Fig. 98 Asia Pacific rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 99 Japan
Fig. 100 Japan rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 101 China
Fig. 102 China rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 103 India
Fig. 104 India rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 105 South Korea
Fig. 106 South Korea rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 107 Singapore
Fig. 108 Singapore rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 109 Australia
Fig. 110 Australia rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 111 South East Asia
Fig. 112 South East Asia rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 113 Latin America
Fig. 114 Latin America rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 115 Brazil
Fig. 116 Brazil rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 117 Middle East & Africa
Fig. 118 MEA rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)
Fig. 119 South Africa
Fig. 120 South Africa rare biomarkers specimen collection & stabilization market estimates and forecast, 2015 - 2027 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.